Related Experiment Videos
Side effect profiles of new antipsychotic agents
1Psychiatry Service (116A), VA Medical Center, Portland, OR 97207, USA.
The Journal of Clinical Psychiatry
|January 1, 1996
Summary
New antipsychotic drugs like olanzapine and sertindole offer improved treatment for psychosis. They provide a better benefit-to-risk ratio by reducing troublesome side effects and enhancing patient quality of life.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Traditional neuroleptic drugs are primary treatments for psychosis but cause significant side effects.
- Extrapyramidal symptoms (EPS) and tardive dyskinesia are particularly challenging side effects.
- Other side effects include seizures, sedation, neuroleptic malignant syndrome, and metabolic issues.
Purpose of the Study:
- To evaluate the efficacy and safety of newer antipsychotic agents.
- To compare the side effect profiles of traditional and novel antipsychotics.
- To assess the impact of new antipsychotics on patient quality of life.
Main Methods:
- Review of existing literature on antipsychotic drug therapy.
- Analysis of clinical trial data for clozapine, risperidone, olanzapine, and sertindole.
- Comparison of side effect profiles, focusing on EPS and other adverse events.
Main Results:
- Clozapine and risperidone improved motor side effect profiles but have dose-limiting side effects.
- Olanzapine and sertindole demonstrate fewer extrapyramidal symptoms and other adverse effects.
- These newer agents enhance the benefit/risk ratio in psychosis treatment.
Conclusions:
- Newer antipsychotic medications significantly improve the treatment of psychosis.
- These drugs reduce drug-induced morbidity and enhance patient quality of life.
- Olanzapine and sertindole represent advancements in managing psychosis with improved safety profiles.